Study on Budesonide in Nasal Rinse for Chronic Sinusitis

Understanding Chronic Sinusitis

Chronic sinusitis is characterized by prolonged inflammation of the nasal cavity lining, lasting over 12 weeks, often accompanied by infection flare-ups. Current treatment guidelines for chronic sinusitis suggest the use of saline rinses, antibiotics, and nasal steroid sprays. Despite their frequent prescription, antibiotics show limited effectiveness for long-term management. In contrast, nasal steroid sprays are recognized for their safety and efficacy, although their penetration into the sinus lining is not optimal.

Research on Delivery Methods

Recent research indicates that nasal irrigation using low pressure and larger volumes may enhance the delivery of topical treatments. To investigate this method, U.S. researchers examined the addition of budesonide, an anti-inflammatory steroid, to nasal saline irrigation for patients suffering from chronic sinusitis. The findings were published in JAMA Otolaryngology-Head & Neck Surgery.

Clinical Trial Design

The clinical trial involved participants aged 18 and older with chronic sinusitis persisting for over 12 weeks. Eligible participants exhibited at least two symptoms associated with chronic sinusitis. The study was designed as a double-blinded, placebo-controlled trial, dividing participants into two groups: one receiving budesonide and the other receiving a placebo (lactose). Participants were instructed to dissolve two capsules in saline and perform nasal rinses daily for 30 days.

Outcome Evaluation

Researchers evaluated outcomes pre- and post-treatment using the Sino Nasal Outcome Test (SNOT 22) scores, along with quality of life improvements based on participant feedback. Out of the recruited participants, 61 completed the study, with 29 in the budesonide group and 32 in the control group.

Results of Budesonide Treatment

The results indicated that the budesonide group experienced a significant average improvement in SNOT-22 scores, with an average difference of 8.5 points compared to the control group. Notably, around 80% of participants in the budesonide group achieved a clinically meaningful score reduction of 9 points or more, while about 60% of the control group reported similar reductions. Furthermore, participants without nasal polyps showed greater symptom improvement from the budesonide treatment than those with polyps.

Implications and Future Research

The study suggests that budesonide delivered through large-volume, low-pressure saline rinses can significantly alleviate chronic sinusitis symptoms compared to saline alone. The high acceptance and affordability of nasal saline rinses further support their use.

However, the researchers acknowledged that the four-week study duration might not fully capture the treatment’s long-term effects. Additionally, compliance was self-reported, raising questions about the consistency of treatment completion among participants.

Overall, while the results highlight the potential benefits of budesonide in managing chronic sinusitis, further large-scale trials are necessary to explore its effectiveness across different patient subgroups and in comparison to other treatment options like nasal steroid sprays.

Reference

Tait, S., Kallogjeri, D., Suko, J., Kukuljan, S., Schneider, J., & Piccirillo, J. F. (2018). Effect of Budesonide Added to Large-Volume, Low-pressure Saline Sinus Irrigation for Chronic Rhinosinusitis. JAMA Otolaryngology–Head & Neck Surgery, 144(7), 605. doi:10.1001/jamaoto.2018.0667